Cetera Investment Advisers
NVO

Cetera Investment Advisers’s Novo Nordisk NVO Stock Holding History

Cetera Investment Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$168 – 4912
2025
Q4 		$168 Buy
+200
New +$10.2K ﹤0.01% 4668

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cetera Investment Advisers's NVO Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Novo Nordisk (NVO) stake by 3.5% in Q2 2026, selling an estimated $604K and leaving 382,507 shares worth $18.3M. The position accounts for 0.02% of the portfolio, ranked #806.

Cetera Investment Advisers first reported a position in NVO in Q3 2018 and has held it in 32 quarters since. The position peaked at $41.5M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Cetera Investment Advisers held 382,507 shares of Novo Nordisk worth $18.3M as of Q2 2026.
  • Cetera Investment Advisers sold 14,050 Novo Nordisk shares in Q2 2026, an estimated $604K.
  • Novo Nordisk made up 0.02% of Cetera Investment Advisers's portfolio in Q2 2026, its #806 holding.
  • Cetera Investment Advisers first reported a position in Novo Nordisk in Q3 2018 and has held it in 32 quarters since.
  • Cetera Investment Advisers's Novo Nordisk position peaked at $41.5M in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.